Healius Limited (ASX:HLS)
Australia · Delayed Price · Currency is AUD 0.4350
+0.0100 (2.35%)
Aug 27, 2026, 4:10 PM AEST
Healius Revenue
In the fiscal year ending June 30, 2026, Healius had annual revenue of 1.37B AUD with 2.16% growth.
Revenue
1.37B
Revenue Growth
+2.16%
P/S Ratio
0.23
Revenue / Employee
228.87K
Employees
6,000
Market Cap
315.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1.37B | 29.00M | 2.16% |
| Jun 30, 2025 | 1.34B | 72.40M | 5.69% |
| Jun 30, 2024 | 1.27B | -435.10M | -25.49% |
| Jun 30, 2023 | 1.71B | -582.00M | -25.43% |
| Jun 30, 2022 | 2.29B | 374.70M | 19.57% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sonic Healthcare | 10.87B |
| Integral Diagnostics | 788.62M |
| Australian Clinical Labs | 736.15M |
| Monash IVF Group | 269.39M |
| ImExHS | 28.97M |
| Genetic Signatures | 20.32M |
| Cryosite | 16.70M |
| Microba Life Sciences | 14.90M |
Healius News
- 8 days ago - Healius Earnings Call Transcript: H2 2026 - Transcripts
- 8 days ago - Healius Slides: H2 2026 - Filings
- 8 days ago - Healius Annual report: H2 2026 - Filings
- 8 days ago - Healius Earnings release: H2 2026 - Filings
- 3 months ago - Healius Earnings release: Trading update - Filings
- 6 months ago - Healius Earnings Call Transcript: H1 2026 - Transcripts
- 6 months ago - Healius Quarterly report: H1 2026 - Filings
- 6 months ago - Healius Slides: H1 2026 - Filings